Author
Listed:
- Jeehye Park
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine)
- Ismael Al-Ramahi
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Qiumin Tan
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine)
- Nissa Mollema
(Institute for Translational Neuroscience, University of Minnesota
University of Minnesota)
- Javier R. Diaz-Garcia
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Tatiana Gallego-Flores
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Hsiang-Chih Lu
(Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Program in Developmental Biology, Baylor College of Medicine)
- Sarita Lagalwar
(Institute for Translational Neuroscience, University of Minnesota
University of Minnesota)
- Lisa Duvick
(Institute for Translational Neuroscience, University of Minnesota
University of Minnesota)
- Hyojin Kang
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Present addresses: Supercomputing Center, Korea Institute of Science and Technology Information, Daejeon 305-806, South Korea (H.K.); Department of Life Science, Pohang University of Science and Technology, Pohang, Kyungbuk 790-784, South Korea (Y.L.).)
- Yoontae Lee
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine
Present addresses: Supercomputing Center, Korea Institute of Science and Technology Information, Daejeon 305-806, South Korea (H.K.); Department of Life Science, Pohang University of Science and Technology, Pohang, Kyungbuk 790-784, South Korea (Y.L.).)
- Paymaan Jafar-Nejad
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Layal S. Sayegh
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Ronald Richman
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine)
- Xiuyun Liu
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine)
- Yan Gao
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Chad A. Shaw
(Baylor College of Medicine)
- J. Simon C. Arthur
(MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK)
- Harry T. Orr
(Institute for Translational Neuroscience, University of Minnesota
University of Minnesota)
- Thomas F. Westbrook
(Baylor College of Medicine
Program in Developmental Biology, Baylor College of Medicine
Baylor College of Medicine)
- Juan Botas
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital)
- Huda Y. Zoghbi
(Baylor College of Medicine
Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital
Howard Hughes Medical Institute, Baylor College of Medicine
Program in Developmental Biology, Baylor College of Medicine)
Abstract
Many neurodegenerative disorders, such as Alzheimer’s, Parkinson’s and polyglutamine diseases, share a common pathogenic mechanism: the abnormal accumulation of disease-causing proteins, due to either the mutant protein’s resistance to degradation or overexpression of the wild-type protein. We have developed a strategy to identify therapeutic entry points for such neurodegenerative disorders by screening for genetic networks that influence the levels of disease-driving proteins. We applied this approach, which integrates parallel cell-based and Drosophila genetic screens, to spinocerebellar ataxia type 1 (SCA1), a disease caused by expansion of a polyglutamine tract in ataxin 1 (ATXN1). Our approach revealed that downregulation of several components of the RAS–MAPK–MSK1 pathway decreases ATXN1 levels and suppresses neurodegeneration in Drosophila and mice. Importantly, pharmacological inhibitors of components of this pathway also decrease ATXN1 levels, suggesting that these components represent new therapeutic targets in mitigating SCA1. Collectively, these data reveal new therapeutic entry points for SCA1 and provide a proof-of-principle for tackling other classes of intractable neurodegenerative diseases.
Suggested Citation
Jeehye Park & Ismael Al-Ramahi & Qiumin Tan & Nissa Mollema & Javier R. Diaz-Garcia & Tatiana Gallego-Flores & Hsiang-Chih Lu & Sarita Lagalwar & Lisa Duvick & Hyojin Kang & Yoontae Lee & Paymaan Jafa, 2013.
"RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1,"
Nature, Nature, vol. 498(7454), pages 325-331, June.
Handle:
RePEc:nat:nature:v:498:y:2013:i:7454:d:10.1038_nature12204
DOI: 10.1038/nature12204
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:498:y:2013:i:7454:d:10.1038_nature12204. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.